Hon CHRIS HIPKINS: I want all New Zealanders to be assured that the Government is prioritising their safety in the way the vaccine is being rolled out. We know from feedback that some of the major reasons for hesitancy towards a vaccine can be related to concerns around its safety. Through our medicines authority, Medsafe, New Zealand has followed a very strict process. Unlike some other countries who have been dealing with rampant public health emergencies, we've not needed to grant any emergency vaccine exemptions. That means that right throughout the Medsafe process, we've been able to take the time and consideration needed to determine that the Pfizer-BioNTech vaccine, and any other vaccines that are under consideration, are safe for use. We have confidence in both the international science involved in developing these vaccines and the processes New Zealand has in place to ensure that any vaccines we use are safe and effective. In answer to the first part of the question regarding distribution, the vaccine will be distributed progressively to more and more communities as supplies allow. 